EGFR and lung cancer: To test the possibility that the EGFR‐mutant tumor cells‐derived products could directly modulate DCs, we co‐cultured iDCs from healthy human blood monocytes with the conditioned medium (CM) collected from EGFR‐mutant or WT lung cancer cells and subsequently induced them to be mature with LPS (Figure S3a, Supporting Information).